Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: HKPD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -60.78% | Avg. Invested days 35 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.81 - 3.79 | Updated Date 05/15/2025 |
52 Weeks Range 0.81 - 3.79 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Company Overview
History and Background
Based on available information, Hong Kong Pharma Digital Technology Holdings Limited does not appear to be a publicly traded US stock. There are no readily available details on its founding, milestones, or evolution as a US-traded entity. It might be a subsidiary, a private company, or listed on a different exchange.
Core Business Areas
Leadership and Structure
Since Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares is not a publicly traded US stock, leadership and organizational structure can not be determined.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
Without information on Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares specific operations, providing a comprehensive industry overview is not possible.
Positioning
Since Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares is not a publicly traded US stock, its position within the industry is unavailable.
Total Addressable Market (TAM)
Without information on Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares specific operations, TAM is not determinable.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Since Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares is not a publicly traded US stock, a comparison to competitors cannot be performed.
Growth Trajectory and Initiatives
Historical Growth: Not available for a company that is not a publicly traded US stock.
Future Projections: Not available for a company that is not a publicly traded US stock.
Recent Initiatives: Not available for a company that is not a publicly traded US stock.
Summary
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares does not appear to be a publicly traded US stock. Therefore, no meaningful analysis can be performed. Information regarding the company's financial performance, market position, and competitors is unavailable. Further investigation would be needed to determine the company's true nature and activities before proceeding with any analysis.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Google Search
- Public financial databases (where available)
Disclaimers:
The analysis is based on the limited available information on Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares and assumes it is attempting to be traded as a US stock. The lack of information impacts the ability to perform a complete assessment. The AI-based rating is for illustrative purposes only and should not be used for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-01-15 | CEO & Chairman of the Board Mr. Lap Sun Wong | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 19 | Website https://www.9zt.hk |
Full time employees 19 | Website https://www.9zt.hk | ||
Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the OTC pharmaceutical business in Hong Kong and Mainland China. It provides OTC pharmaceutical cross-border e-commerce supply chain; and procurement and distribution services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. Hong Kong Pharma Digital Technology Holdings Limited was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.